USA – Bristol-Myers Squibb (BMS) announced that the first drug in a new class of cancer immunotherapies has been approved by US FDA as an initial treatment for advanced melanoma,…
Read MoreTag: melanoma
NICE okays Merck’s Keytruda, giving it parity with Opdivo for adjuvant melanoma
UNITED KINGDOM – Merk & Co’s checkpoint inhibitor Keytruda, which has been available for three years through the Cancer Drugs Fund (CDF), has now been approved for routine NHS use…
Read MoreZydus Cadila gets USFDA approval to market generic cancer drug in US
USA – Zydus Cadila, a pharmaceutical company, has announced that it has received approval from the US Food and Drug Administration to market Decitabine injection, which is used to treat…
Read MoreFujifilm Diosynth Biotechnologies, Istari Oncology ties up deal to advance solid tumor drug production
USA – FUJIFILM Diosynth Biotechnologies (FDB) and Istari Oncology have announced that they have reached an agreement for the manufacture of PVSRIPO, a viral immunotherapy being developed by Istari Oncology…
Read More